These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 10655553)

  • 1. Functional analysis of novel mutations in y(+)LAT-1 amino acid transporter gene causing lysinuric protein intolerance (LPI).
    Mykkänen J; Torrents D; Pineda M; Camps M; Yoldi ME; Horelli-Kuitunen N; Huoponen K; Heinonen M; Oksanen J; Simell O; Savontaus ML; Zorzano A; Palacín M; Aula P
    Hum Mol Genet; 2000 Feb; 9(3):431-8. PubMed ID: 10655553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene.
    Torrents D; Mykkänen J; Pineda M; Feliubadaló L; Estévez R; de Cid R; Sanjurjo P; Zorzano A; Nunes V; Huoponen K; Reinikainen A; Simell O; Savontaus ML; Aula P; Palacín M
    Nat Genet; 1999 Mar; 21(3):293-6. PubMed ID: 10080182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of a membrane protein (y+L amino acid transporter-1) that associates with 4F2hc to encode the amino acid transport activity y+L. A candidate gene for lysinuric protein intolerance.
    Torrents D; Estévez R; Pineda M; Fernández E; Lloberas J; Shi YB; Zorzano A; Palacín M
    J Biol Chem; 1998 Dec; 273(49):32437-45. PubMed ID: 9829974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of normal and mutant GFP-tagged y(+)L amino acid transporter-1 in mammalian cells.
    Toivonen M; Mykkänen J; Aula P; Simell O; Savontaus ML; Huoponen K
    Biochem Biophys Res Commun; 2002 Mar; 291(5):1173-9. PubMed ID: 11883940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A y(+)LAT-1 mutant protein interferes with y(+)LAT-2 activity: implications for the molecular pathogenesis of lysinuric protein intolerance.
    Sperandeo MP; Paladino S; Maiuri L; Maroupulos GD; Zurzolo C; Taglialatela M; Andria G; Sebastio G
    Eur J Hum Genet; 2005 May; 13(5):628-34. PubMed ID: 15756301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance.
    Borsani G; Bassi MT; Sperandeo MP; De Grandi A; Buoninconti A; Riboni M; Manzoni M; Incerti B; Pepe A; Andria G; Ballabio A; Sebastio G
    Nat Genet; 1999 Mar; 21(3):297-301. PubMed ID: 10080183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids.
    Pineda M; Fernández E; Torrents D; Estévez R; López C; Camps M; Lloberas J; Zorzano A; Palacín M
    J Biol Chem; 1999 Jul; 274(28):19738-44. PubMed ID: 10391915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of LPI-causing mutations on y+LAT1 function and localization.
    Rotoli BM; Barilli A; Ingoglia F; Visigalli R; Bianchi MG; Ferrari F; Martinelli D; Dionisi-Vici C; Dall'Asta V
    Orphanet J Rare Dis; 2019 Mar; 14(1):63. PubMed ID: 30832686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLC7A7 genomic structure and novel variants in three Japanese lysinuric protein intolerance families.
    Noguchi A; Shoji Y; Koizumi A; Takahashi T; Matsumori M; Kayo T; Ohata T; Wada Y; Yoshimura I; Maisawa S; Konishi M; Takasago Y; Takada G
    Hum Mutat; 2000; 15(4):367-72. PubMed ID: 10737982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of y+LAT1 and 4F2hc in the y+l amino acid transporter complex: consequences of lysinuric protein intolerance-causing mutations.
    Toivonen M; Tringham M; Kurko J; Terho P; Simell O; Heiskanen KM; Mykkänen J
    Gen Physiol Biophys; 2013 Dec; 32(4):479-88. PubMed ID: 23940088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cationic amino acid transporter gene hCAT-2 is assigned to 8p22 but is not the causative gene in lysinuric protein intolerance.
    Lauteala T; Horelli-Kuitunen N; Closs E; Savontaus MI; Lukkarinen M; Simell O; Cunningham J; Palotie A; Aula P
    Hum Genet; 1997 Jul; 100(1):80-3. PubMed ID: 9225973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and genetic features of lysinuric protein intolerance in Japan.
    Noguchi A; Nakamura K; Murayama K; Yamamoto S; Komatsu H; Kizu R; Takayanagi M; Okuyama T; Endo F; Takasago Y; Shoji Y; Takahashi T
    Pediatr Int; 2016 Oct; 58(10):979-983. PubMed ID: 26865117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two alternative promoters regulate the expression of lysinuric protein intolerance gene SLC7A7.
    Puomila K; Simell O; Huoponen K; Mykkänen J
    Mol Genet Metab; 2007 Mar; 90(3):298-306. PubMed ID: 17196863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic homogeneity of lysinuric protein intolerance.
    Lauteala T; Mykkänen J; Sperandeo MP; Gasparini P; Savontaus ML; Simell O; Andria G; Sebastio G; Aula P
    Eur J Hum Genet; 1998; 6(6):612-5. PubMed ID: 9887380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prioritization of SNPs in y+LAT-1 culpable of Lysinuric protein intolerance and their mutational impacts using protein-protein docking and molecular dynamics simulation studies.
    Gopalakrishnan C; Al-Subaie AM; N N; Yeh HY; Tayubi IA; Kamaraj B
    J Cell Biochem; 2019 Oct; 120(10):18496-18508. PubMed ID: 31211457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of system y(+)-like amino acid transport by the heavy chain of human 4F2 surface antigen in Xenopus laevis oocytes.
    Bertran J; Magagnin S; Werner A; Markovich D; Biber J; Testar X; Zorzano A; Kühn LC; Palacin M; Murer H
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5606-10. PubMed ID: 1376926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysinuric protein intolerance: update and extended mutation analysis of the SLC7A7 gene.
    Sperandeo MP; Andria G; Sebastio G
    Hum Mutat; 2008 Jan; 29(1):14-21. PubMed ID: 17764084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. y+LAT1 and y+LAT2 contribution to arginine uptake in different human cell models: Implications in the pathophysiology of Lysinuric Protein Intolerance.
    Rotoli BM; Barilli A; Visigalli R; Ferrari F; Dall'Asta V
    J Cell Mol Med; 2020 Jan; 24(1):921-929. PubMed ID: 31705628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slc7a7 disruption causes fetal growth retardation by downregulating Igf1 in the mouse model of lysinuric protein intolerance.
    Sperandeo MP; Annunziata P; Bozzato A; Piccolo P; Maiuri L; D'Armiento M; Ballabio A; Corso G; Andria G; Borsani G; Sebastio G
    Am J Physiol Cell Physiol; 2007 Jul; 293(1):C191-8. PubMed ID: 17376816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysinuric protein intolerance: identification and functional analysis of mutations of the SLC7A7 gene.
    Sperandeo MP; Annunziata P; Ammendola V; Fiorito V; Pepe A; Soldovieri MV; Taglialatela M; Andria G; Sebastio G
    Hum Mutat; 2005 Apr; 25(4):410. PubMed ID: 15776427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.